CareCloud (MTBC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
25 Dec, 2025Executive summary
Achieved record profitability in 2024, with GAAP net income of $7.9M, adjusted EBITDA of $24.1M (up 56%), and free cash flow of $13.2M (up 244%), despite a modest revenue decline.
Strategic focus on operational efficiency, cost-cutting, and leveraging proprietary AI technology drove margin improvements and record cash flow.
Completed a significant Series A preferred stock conversion, reducing annual dividend obligation by $7.7M, simplifying the capital structure, and aligning shareholder interests.
Fully repaid $10M credit line using internally generated cash, strengthening the balance sheet.
Re-entered the acquisition market with a small deal and plans to resume accretive acquisition strategy.
Financial highlights
FY 2024 revenue was $110.8M, down from $117.1M in 2023; Q4 2024 revenue was $28.2M, nearly flat year-over-year.
Adjusted EBITDA for FY 2024 was $24.1M, up from $15.4M in 2023; Q4 adjusted EBITDA was $7.1M, up 73% year-over-year.
Free cash flow for FY 2024 was $13.2M, compared to $3.8M in 2023; $10M used to repay line of credit.
Adjusted net income for 2024 was $10.5M ($0.65/share); Q4 adjusted net income was $3.9M ($0.24/share).
Net working capital at year-end was $5.2M, up from a deficit of $57,000 the prior year; cash balance was $5.1M.
Outlook and guidance
2025 revenue guidance: $111M–$114M, marking a return to revenue growth after prior declines.
Adjusted EBITDA projected at $26M–$28M; EPS expected between $0.10 and $0.13, first positive EPS since IPO.
Guidance assumes organic growth, small tuck-in acquisitions, and continued cost reduction efforts.
Plans to launch innovative, integrated AI solutions and resume accretive acquisition strategy.
Latest events from CareCloud
- Q2 2026 revenue up 16% to $31.9M, with lower net income and a streamlined capital structure.MTBC
Q2 2026 - Q1 2026 revenue up 13% to $31.3M, recurring revenue at 74%, and capital structure streamlined.MTBC
Q1 2026 - Annual meeting to vote on Board nominees, executive pay, equity plan, and auditor approval.MTBC
Proxy filing - Annual meeting to vote on directors, executive pay, equity plan, and auditor, with board support.MTBC
Proxy filing - AI-powered healthcare IT solutions drive growth, efficiency, and expanded market reach.MTBC
Investor presentation - 2025 saw record revenue, positive EPS, and AI-driven growth, with strong 2026 outlook.MTBC
Q4 2025 - Record free cash flow and profitability achieved; preferred dividends resume March 2025.MTBC
Q3 2024 - First positive GAAP net income since 2022, with strong EBITDA and free cash flow growth.MTBC
Q2 2024 - AI-driven healthcare platform achieves record free cash flow and resumes strategic acquisitions.MTBC
15th Annual LD Micro Invitational 2025